沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

交易中 02-26 10:39:01

5.910

-0.170

-2.80%

最高6.090	最低5.910	成交量9.60万
今开6.080	昨收6.080	日振幅2.96%
总市值39.72亿	流通市值39.72亿	总股本6.72亿
成交额57.55万	换手率0.01%	流通股本6.72亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":5.91,"timestamp":1772073448053,"preClose":6.08,"halted":0,"volume":96000,"delay":0,"changeRate":-0.02796052631578946,"floatShares":672000000,"shares":672000000,"eps":-0.338431,"marketStatus":"交易中","change":-0.17,"latestTime":"02-26 10:39:01","open":6.08,"high":6.09,"low":5.91,"amount":575490,"amplitude":0.029605,"askPrice":5.94,"askSize":16000,"bidPrice":5.9,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.372288,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1772078400000},"marketStatusCode":2,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":6.08,"openAndCloseTimeList":[[1772069400000,1772078400000],[1772082000000,1772092800000]],"volumeRatio":0.931178,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2614708399","title":"每日卖空追踪 | 沛嘉医疗-B 02月25日卖空量成交4000股，卖空比例为1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614708399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614708399?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008248,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间02月25日，跌2.09%，卖空量成交4000股，较上一交易日减少94.03%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163644a4c6780c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163644a4c6780c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1100","BK1574","BK1583"],"gpt_icon":0},{"id":"2614046770","title":"2025消费大复盘：万店不稀罕，千亿才刚及格","url":"https://stock-news.laohu8.com/highlight/detail?id=2614046770","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614046770?lang=zh_cn&edition=full","pubTime":"2026-02-25 14:46","pubTimestamp":1772002010,"startTime":"0","endTime":"0","summary":"六大上市茶饮巨头2025年上半年合计净利润突破55亿元，交出了一份傲人的成绩单。2025年上半年，这家卖4元柠檬水的企业营收148.75亿元，净利润27.18亿元，同比增长44.1%。海外门店达208家，覆盖6个国家，2025年上半年海外GMV同比增长77.4%。截至2025年11月，库迪全国门店总数达15791家，90天内新增2784家，覆盖全国360个城市。以京东七鲜为例，截至2025年10月，七鲜自有品牌商品成交额同比增长445%，SKU数量突破600个，覆盖全品类。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1770969678699708521","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU1188198961.HKD","BK4585","IE00BGV7N243.SGD","LU0593848301.USD","LU0871576103.HKD","BK4558","LU0348766576.USD","SG9999002950.SGD","09633","BK4551","LU0307460666.USD","LU2543165471.USD","LU0164865239.USD","BK4505","LU0345776255.USD","BK4122","LU0359202008.SGD","LU0499858602.USD","BK4526","LU0164880469.USD","LU0531971595.HKD","BK4524","BK4531","BK4503","HK0000320223.HKD","LU0327786744.USD","LU0823426480.USD","BK4579","LU1770036033.HKD","NNFSF","LU0499858438.USD","LU0231483743.USD","LU0359201885.HKD","LU0345775950.USD","LKNCY","LU1688375341.USD","BK4504","LU0244354667.USD","HK0000306685.HKD","BK1224","LU0823426308.USD","HK0000306701.USD","LU0348767384.USD","LU1023057109.AUD","LU0588546209.SGD","IE0034224299.USD","BK4614","LU0611395673.USD","LU0463099449.HKD","LU1481107354.HKD","SG9999001069.SGD","09992","LU0572944931.SGD","SGXZ86797644.SGD","HK0000320264.USD","BK4588","LU0359201612.USD","LU0106959298.USD","SGXZ62798434.SGD","LU0149721374.USD","IE0008368742.USD","BK4509","LU1880383366.USD","BK4220","605499","09980","KJD","LU0039217434.USD","PMRTY","LU0326950275.SGD","SG9999002463.SGD","LU0211977185.USD","09996"],"gpt_icon":1},{"id":"2613797713","title":"敷尔佳（301371）披露第三类医疗器械产品完成临床试验公告，2月24日股价上涨0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613797713","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613797713?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:49","pubTimestamp":1771930152,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，敷尔佳报收于24.91元，较前一交易日上涨0.12%，最新总市值为129.56亿元。该股当日开盘25.1元，最高25.24元，最低24.6元，成交额达4956.79万元，换手率为2.57%。公司于近日披露《关于第三类医疗器械产品完成临床试验的公告》。公告显示，哈尔滨敷尔佳科技股份有限公司在研产品“重组Ⅲ型人源化胶原蛋白冻干纤维”已完成临床试验并取得临床试验总结报告，可以进行注册申报材料递交。国内外同类医疗器械产品较少，国内市场潜力较大。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400037704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","09997","301371","BK1222","BK0229","BK1100","159883","09996","BK1574"],"gpt_icon":0},{"id":"2613229792","title":"安图生物（603658）披露公司及全资子公司获得医疗器械注册证的公告，2月24日股价上涨0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613229792","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613229792?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:22","pubTimestamp":1771928540,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，安图生物报收于36.29元，较前一交易日上涨0.3%，最新总市值为207.37亿元。该股当日开盘36.24元，最高36.37元，最低36.1元，成交额达6235.5万元，换手率为0.3%。近日，郑州安图生物工程股份有限公司及全资子公司安图实验仪器（郑州）有限公司收到河南省药品监督管理局颁发的医疗器械注册证。上述产品用于体外定量检测人血清或血浆中相应物质含量，或用于对液体中细胞进行多参数快速定量分析。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400036534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK1583","BK0239","BK1222","BK1100","603658","BK1574","09996","159883","BK0046"],"gpt_icon":0},{"id":"2613714551","title":"每日卖空追踪 | 沛嘉医疗-B 02月24日卖空量成交2.6万股，卖空比例为5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613714551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613714551?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:30","pubTimestamp":1771921841,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间02月24日，跌2.2%，卖空量成交2.6万股，较上一交易日减少25.71%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163643a7191edb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163643a7191edb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1100","09996"],"gpt_icon":0},{"id":"2613721128","title":"每日卖空追踪 | 沛嘉医疗-B 02月20日卖空量成交1万股，卖空比例为1.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613721128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613721128?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576241,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间02月20日，涨0.65%，卖空量成交1万股，较上一交易日减少16.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163559a70cd199&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163559a70cd199&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09996","BK1100","BK1583"],"gpt_icon":0},{"id":"2611170422","title":"港股异动 | 微创心通-B(02160)涨超6% 植入式心律转复除颤器进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2611170422","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611170422?lang=zh_cn&edition=full","pubTime":"2026-02-16 11:27","pubTimestamp":1771212433,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，微创心通-B涨超6%，截至发稿，涨6.33%，报0.84港元，成交额859.92万港元。消息面上，2月13日晚，微创心通发布公告称，近日，国家药品监督管理局“NMPA”医疗器械技术审评中心发布《创新医疗器械特别审查申请审查结果公示》，拟同意集团旗下新一代植入式心律转复除颤器TILEN/EYLEN 进入创新医疗器械特别审查程序。据此 ，TILEN/EYLEN有望成为国内首款获批的具备自主知识产权的磁共振条件安全ICD。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405665.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["09996","BK1583","VXUS","BK1100","VT","02160","09997","BK4585","159883","BK1222","BK4588","BK1574"],"gpt_icon":0},{"id":"2611651851","title":"微创心通-B(02160)：植入式心律转复除颤器进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2611651851","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611651851?lang=zh_cn&edition=full","pubTime":"2026-02-13 23:03","pubTimestamp":1770994990,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创心通-B 发布公告，近日，国家药品监督管理局“NMPA”医疗器械技术审评中心发布《创新医疗器械特别审查申请审查结果公示》，拟同意集团旗下新一代植入式心律转复除颤器TILEN/EYLEN 进入创新医疗器械特别审查程序。此次TILEN/EYLEN进入NMPA绿色通道，有望加速磁共振条件安全ICD的国产化进程。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1583","BK1100","02160","09997","159883","BK1222","BK1574"],"gpt_icon":0},{"id":"2611813478","title":"中生北控生物科技(08247)附属中生医疗自主研发的BioCyte 系列流式细胞仪获发马来西亚医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2611813478","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611813478?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:43","pubTimestamp":1770972201,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中生北控生物科技 发布公告，本公司的附属公司中生(苏州)医疗科技有限公司自主研发的BioCyte 系列流式细胞仪，近日成功通过马来西亚医疗器械管理局的审核，正式获得马来西亚医疗器械注册证，注册编号为IVDA9463526–225393。BioCyte系列流式细胞仪凭藉稳定性能及检测准确性，已在国内市场获得应用。中生医疗依据当地相关法规要求，完成产品检测、技术资料提交及审核程式，最终获得马来西亚医疗器械管理局批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","159891","08247","BK1574","BK1222","BK1161","BK1100","09996","BK1583","09997"],"gpt_icon":0},{"id":"2611313360","title":"心力衰竭医疗器械开发商BioVentrix(BVXX.US)申请在美IPO 拟募资1700万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611313360","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611313360?lang=zh_cn&edition=full","pubTime":"2026-02-13 14:57","pubTimestamp":1770965856,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于研发心力衰竭微创治疗技术的医疗器械公司BioVentrix于周四向美国证券交易委员会提交申请，拟通过首次公开募股筹集至多1700万美元资金。BioVentrix是一家研发并商业化用于治疗射血分数降低型心力衰竭的医疗器械公司。BioVentrix此前曾通过销售Revivent TC经导管心室增强系统获得收入，该产品已于2023年停止销售以节约资金。BioVentrix已于2025年8月5日秘密提交上市申请。本次IPO由The Benchmark Company独家担任账簿管理人，暂未披露发行定价条款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1222","09997","BK1100","09996","BK1583","159883"],"gpt_icon":0},{"id":"2610956825","title":"每日卖空追踪 | 沛嘉医疗-B 02月11日卖空量成交9000股，卖空比例为1.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610956825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610956825?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:30","pubTimestamp":1770798646,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间02月11日，跌2.17%，卖空量成交9000股，较上一交易日减少75.68%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163632a6ee20e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163632a6ee20e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","09996","BK1574","BK1100"],"gpt_icon":0},{"id":"2610956840","title":"沛嘉医疗-B02月11日主力净流出80.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2610956840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610956840?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:15","pubTimestamp":1770797747,"startTime":"0","endTime":"0","summary":"02月11日, 沛嘉医疗-B股价跌2.17%，报收6.30元，成交金额453.5万元，换手率0.11%，振幅4.50%，量比1.15。沛嘉医疗-B今日主力资金净流出80.1万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.33%，主力资金累计净流出34.6万元；近20日主力资金累计净流出543.7万元，其中净流出天数为9日。该股主力净额占比0.02%，港股市场排名2531/2717。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161952a6ee0ce8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161952a6ee0ce8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","09996","BK1100","BK1574"],"gpt_icon":0},{"id":"2610073856","title":"创新放量，交易升温！中国创新医疗器械发展迈入新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2610073856","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610073856?lang=zh_cn&edition=full","pubTime":"2026-02-11 09:54","pubTimestamp":1770774857,"startTime":"0","endTime":"0","summary":"在国家的大力支持下，我国创新医疗器械在近年来发展正突飞猛进。此外，2025年国家药监局公告进入创新医疗器械特别审查程序的产品数量也已高达122款，相比2024年接近翻倍。值得一提的是，随着国产医疗器械创新能力的不断提升，近两年来，中国创新医疗器械收购交易也正逐渐起势。总的来说，中国创新医疗器械产业正处在由大向强转变、换道超车的重要关口期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211095929a495c7e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211095929a495c7e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1574","BK1100","02190","BK1587","09997","BK1222","BK1583"],"gpt_icon":0},{"id":"2610678139","title":"每日卖空追踪 | 沛嘉医疗-B 02月10日卖空量成交6000股，卖空比例为1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610678139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610678139?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:30","pubTimestamp":1770712245,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间02月10日，涨0.63%，卖空量成交6000股，较上一交易日减少93.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163629a492bd72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163629a492bd72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","09996","BK1583","BK1574"],"gpt_icon":0},{"id":"2610832633","title":"广西北海市开展春节前医疗器械监督检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2610832633","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610832633?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:51","pubTimestamp":1770627060,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 春节将至，为切实保障群众节日期间用械安全，规范医疗器械市场秩序，近日，广西北海市市场监管部门开展春节前医疗器械质量安全监督检查行动，以强监管、严排查、守底线，守护群众健康过年。行动中，北海市市场监管部门坚持监管与服务并重，推动形成闭环管理。下一步，北海市市场监管部门将持续强化动态巡查，畅通投诉举报渠道，全力守护群众春节期间用械安全，保障人民群众度过平安祥和的新春佳节。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-09/doc-inhmfivm6305424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09997","BK1574","159883","BK1100","BK1583","BK1222","09996"],"gpt_icon":0},{"id":"2610800226","title":"九强生物最新公告：取得纤维蛋白（原）降解产物测定试剂盒医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2610800226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610800226?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:43","pubTimestamp":1770626583,"startTime":"0","endTime":"0","summary":"九强生物公告称，公司近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品为纤维蛋白（原）降解产物测定试剂盒，注册证编号为京械注准20262400041，注册类别为Ⅱ类，有效期至2031年2月4日。该试剂盒用于体外定量检测人血浆中的纤维蛋白（原）降解产物含量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900020612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK1574","BK1222","BK1100","BK1583","09997","300406","BK0028","BK0077","159883","09996","BK0239","BK0012"],"gpt_icon":0},{"id":"2610027405","title":"海南自贸港医疗器械保税维修业务 首次实现全流程闭环","url":"https://stock-news.laohu8.com/highlight/detail?id=2610027405","media":"海口网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610027405?lang=zh_cn&edition=full","pubTime":"2026-02-09 10:31","pubTimestamp":1770604260,"startTime":"0","endTime":"0","summary":"记者从海口海关获悉，近日，首批适用“执行例外措施”政策的区外保税维修货物已在海口国家高新区完成全部维修流程，并从海口美兰机场口岸复运出境，这标志着海南自贸港医疗器械保税维修业务首次实现“进口—维修—复运出境”全流程闭环。该项目允许企业在海关全程监管下，接收来自全球的自产待修医疗器械设备，开展检测、维修及功能升级服务，维修完成后直接复运出境。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-02-09/doc-inhmesxq2352301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09996","BK1574","159883","BK1222","BK1583","BK1100","09997"],"gpt_icon":0},{"id":"2610068865","title":"沛嘉医疗-B(09996)：提交GeminiOne® 经导管缘对缘修复系统的EU MDR CE标志注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2610068865","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610068865?lang=zh_cn&edition=full","pubTime":"2026-02-09 08:13","pubTimestamp":1770596006,"startTime":"0","endTime":"0","summary":"智通财经APP讯，沛嘉医疗-B 发布公告，公司已于近日正式提交用于治疗二尖瓣反流的GeminiOne经导管缘对缘修复系统的 EU MDR CE标志注册申请，HighLife SAS为其欧洲合作伙伴。提交CE标志注册申请意味着公司在推进全球化战略方面取得稳步进展。GeminiOne是公司内部研发的创新TEER装置。于本公告日期，GeminiOne的注册申请已获中华人民共和国国家药品监督管理局受理，并正在审评中。此外，GeminiOne已获美国食品药品监督管理局批准其临床试验用器械豁免，以开展早期可行性研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","CE","09996","BK1583","BK4588","BK4585","BK4156","BK4109","159891","EU","BK1574"],"gpt_icon":0},{"id":"2609526452","title":"开年两标 | 合景建设中标马来西亚医疗器械GMP洁净工程项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2609526452","media":"PCBworld","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609526452?lang=zh_cn&edition=full","pubTime":"2026-02-07 11:03","pubTimestamp":1770433408,"startTime":"0","endTime":"0","summary":"—— 2026 ——中标喜讯精益建设，以品质筑非凡2026年合景建设华章再启开年首月连中两标2月4日合景建设旗下海外公司洲际建设（马来西亚）有限公司成功中标国家重点高新技术企业新三板上市公司某医疗器械公司马来西亚新山工程项目续写中国工程企业在海外高端制造业建设领域的崭新篇章合景建设以“中国智慧”对话“全球市场”以“品质工程”服务“信任托付”助力制造业发展该公司是一家专注于临床医疗设备研发与制造的上","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020712480895403a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020712480895403a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1100","BK1574","BK1222","BK1229","03913","BK1583","BK1542","BK1258","09997"],"gpt_icon":0},{"id":"2609255782","title":"沛嘉医疗-B盘中异动 早盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609255782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609255782?lang=zh_cn&edition=full","pubTime":"2026-02-06 10:00","pubTimestamp":1770343205,"startTime":"0","endTime":"0","summary":"2026年02月06日早盘10时00分，沛嘉医疗-B股票出现波动，股价急速跳水5.17%。截至发稿，该股报6.050港元/股，成交量13.9万股，换手率0.02%，振幅3.29%。沛嘉医疗-B股票所在的医疗设备及用品行业中，整体跌幅为0.35%。沛嘉医疗-B公司简介：沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020610000597a51d30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020610000597a51d30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1574","BK1583","BK1100"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":-0.0082},{"period":"1month","weight":-0.0788},{"period":"3month","weight":0.1301},{"period":"6month","weight":-0.1795},{"period":"1year","weight":0.414},{"period":"ytd","weight":0.0116}],"compareEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0},{"period":"3month","weight":0.0316},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.162},{"period":"ytd","weight":0.0443}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.057115},{"month":2,"riseRate":0.5,"avgChangeRate":0.019787},{"month":3,"riseRate":0.4,"avgChangeRate":-0.110838},{"month":4,"riseRate":0.75,"avgChangeRate":0.044776},{"month":5,"riseRate":0.75,"avgChangeRate":-0.061692},{"month":6,"riseRate":0.666667,"avgChangeRate":0.07739},{"month":7,"riseRate":0.5,"avgChangeRate":0.047595},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.086603},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014494},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005393},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.083675}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}